Korean Journal of Microbiology (미생물학회지)

The Microbiological Society of Korea (한국미생물학회)
권호 표지

Real-Time RT-PCR for Validation of Reovirus Type 3 Safety During the Manufacture of Mammalian Cell Culture-Derived Biopharmaceuticals

세포배양 유래 생물의약품 생산 공정에서 Reovirus Type 3 안전성 검증을 위한 Real-Time RT-PCR

  • Lee, Dong-Hyuck (Department of Biological Sciences, Hannam University) ;
  • Jeong, Hyo-Sun (Tissue Engineering Division, Research and Development Dept., Hans Daedeok R&D Center, Hans Biomed Corp.) ;
  • Kim, Tae-Eun (Department of Biological Sciences, Hannam University) ;
  • Oh, Seon-Hwan (Department of Biological Sciences, Hannam University) ;
  • Lee, Jung-Suk (Tissue Engineering Division, Research and Development Dept., Hans Daedeok R&D Center, Hans Biomed Corp.) ;
  • Kim, In-Seop (Department of Biological Sciences, Hannam University)
  • 이동혁 (한남대학교 생명.나노과학대학 생명과학과) ;
  • 정효선 (한스바이오메드(주) 한스대덕연구소) ;
  • 김태은 (한남대학교 생명.나노과학대학 생명과학과) ;
  • 오선환 (한남대학교 생명.나노과학대학 생명과학과) ;
  • 이정숙 (한스바이오메드(주) 한스대덕연구소) ;
  • 김인섭 (한남대학교 생명.나노과학대학 생명과학과)
  • Published : 2008.09.30
Download PDF
⟨ Previous Next ⟩

Abstract

Validation of viral safety is essential in ensuring the safety of mammalian cell culture-derived biopharmaceuticals, because numerous adventitious viruses have been contaminated during the manufacture of the products. Mammalian cells are highly susceptible to Reovirus type 3 (Reo-3), and there are several reports of Reo-3 contamination during the manufacture of biopharmaceuticals. In order to establish the validation system for the Reo-3 safety, a real-time RT-PCR method was developed for quantitative detection of Reo-3 in cell lines, raw materials, manufacturing processes, and final products as well as Reo-3 clearance validation. Specific primers for amplification of Reo-3 RNA was selected, and Reo-3 RNA was quantified by use of SYBR Green I. The sensitivity of the assay was calculated to be $3.2{\times}10^0\;TCID_{50}/ml$. The real-time RT-PCR method was proven to be reproducible and very specific to Reo-3. The established real-time RT-PCR assay was successfully applied to the validation of Chinese hamster ovary (CHO) cell artificially infected with Reo-3. Reo-3 RNA could be quantified in CHO cell as well as culture supernatant. When the real-time RT-PCR assay was applied to the validation of virus removal during a virus filtration process, the result was similar to that of virus infectivity assay. Therefore, it was concluded that this rapid, specific, sensitive, and robust assay could replace infectivity assay for detection and clearance validation of Reo-3.

세포배양 유래 생물의 약품 생산 공정에서 다양한 바이러스가 오염된 사례가 있기 때문에 바이러스 안전성 검증이 필수적이다. Reovirus type 3 (Reo-3)는 동물 세포주와 동물 세포 배양 공정에 오염되는 대표적인 바이러스이다. 세포배양 유래 생물의약품의 Reo-3 안전성을 확보하기 위해, 세포주, 원료물질, 제조공정, 완제품에서 Reo-3를 정략적으로 검출하고, 제조공정에서 Reo-3 제거 검증을 위한 시험법으로 활용이 가능한 real-time RT-PCR 시험법을 확립하였다. Reo-3에 특이적인 primer를 선별하였으며, 형광염료 SYBR Green I을 사용하여 Reo-3 RNA 정략 검출 시험법을 최적화하였다. 세포배양법에 의한 감염역가와 비교한 결과 real-time RT-PCR 민감도는 $3.2{\times}10^0\;TCID_{50}/ml$이었다. 확립된 시험법의 신뢰성(reliability)을 보증하기 위해 시험법 검증을 실시한 결과 특이성(specificity)과 재현성(reproducibility)이 우수함을 확인하였다. 확립된 real-time RT-PCR을 생물의약품 제조공정 검증에 적용할 수 있는지 확인하기 위하여 인위적으로 Reo-3를 오염시킨 CHO 세포에서 Reo-3 검출 시험을 실시한 결과 Reo-3를 감염시킨 CHO 세포와 세포배양 상청액에서 Reo-3를 정략적으로 검출할 수 있었다. 또한 바이러스필터 공정에서 Reo-3제거 효과를 감염역가 시험법과 비교 검증한 결과 더 빠른 시간에 동일한 결과를 얻을 수 있었다. 위와 같은 결과에서 확립된 Reo-3 real-time RT-PCR 시험법은 생물의약품 안전성 보증을 위한 세포주 검증, 생물의 약품 생산 공정 검증, 바이러스 제거 공정 검증 등에서 감염 역가 시험법을 대신할 수 있는 신속하고, 특이성과 민감성이 우수한 시험법임을 확인하였다.

Keywords

References

  1. 길태건, 김원중, 이동혁, 강용, 성학모, 유시형, 박순희, 김인섭. 2005. 혈장분획제제 제조공정에서 크로마토그래피 세척 검증을 위한 모델바이러스로서의 porcine parvovirus 정량. 미생물학회지 41, 216-224
  2. 류승렬, 신진호, 백선영, 김재옥, 민경일, 민복순, 김병국, 김도근, 박미경, 안미진, 채경숙, 정혜성, 이석호, 박순희. 2003. 세포배양 유래 생물의약품 중 bovine viral diarrhoea virus 검출을 위한 RT-PCR, real-time RT-PCR 및 RT-PCR-ELISA 기법의 검출한계와 정량범위 평가. J. Bacteriol. Virol. 33, 161-168
  3. 이동혁, 조항미, 김현미, 이정숙, 김인섭. 2008. 세포배양 유래 생물의약품 생산 공정에서 minute virus of mice 안전성 검증을 위한 real-time PCR. 한국미생물.생명공학회지 36, 12-20
  4. 이동혁, 정효선, 이정희, 김태은, 이정숙, 김인섭. 2008. Bovine herpesvirus type 1 정량 검출을 위한 real-time PCR. 미생물학회지 44, 14-21
  5. Arden, N. and M.J. Betenbaugh. 2004. Life and death in mammalian cell culture: strategies for apoptosis inhibition. Trends Biotechnol. 22, 174-180 https://doi.org/10.1016/j.tibtech.2004.02.004
  6. Barthold, S.W. 1993. Infectivity, disease patterns, and serologic profiles of reovirus serotype 1, 2, and 3 in infant and weanling mice. Lab. Animal Sci. 43, 425-430
  7. Celis, P. and G. Silvester. 2004. European regulatory guidance on virus safety of recombinant proteins, monoclonal antibodies and plasma derived medicinal products. Dev. Biol. Stand. 118, 3-10
  8. Darling, A. 2002. Validation of biopharmaceutical purification process for virus clearance evaluation. Mol. Biotechnol. 21, 57-83 https://doi.org/10.1385/MB:21:1:057
  9. Gallagher, E.M. and A.B. Margolin. 2007. Development of an integrated cell culture-real-time RT-PCR assay for detection of reovirus in biosolids. J. Virol. Methods 139, 195-202 https://doi.org/10.1016/j.jviromet.2006.10.001
  10. Garnick, R.L. 1996. Experience with viral contamination in cell culture. Dev. Biol. Stand. 88, 49-56
  11. Garnick, R.L. 1998. Raw materials as a source of contamination in large-scale cell culture. Dev. Biol. Stand. 93, 21-29
  12. Horaud, F. 1991. Introductory remark: viral safety of biologicals. Dev. Biol. Stand. 75, 3-7
  13. International Conference on Harmonisation. 1998. Guidance on viral safety evaluation of biotechnology products derived from cell lines of human or animal origin; availability. Federal Resister 63, 51074-51084
  14. Jeong, H.S., J.H. Shin, Y.N. Park, J.Y. Choi, Y.L. Kim, B.G. Kim, S.R. Ryu, S.Y. Baek, S.H. Lee, and S.N. Park. 2003. Development of real-time RT-PCR for evaluation of JEV clearance during purification of HPV type 16 L1 virus-like particles. Biologicals 31, 223-229 https://doi.org/10.1016/S1045-1056(03)00064-2
  15. Karpas, A., J. Cawley, and J. Nagington. 1977. Serum-born reovirus type 1 infection of cultured haemic cell lines. J. Gen. Virol. 35, 191-195 https://doi.org/10.1099/0022-1317-35-1-191
  16. Kim, H.J., Y.O. Shin, and S.H. Kim. 2006. Detection of enteroviruses and mammalian reoviruses in Korean environmental waters. Microbiol. Immunol. 50, 781-786 https://doi.org/10.1111/j.1348-0421.2006.tb03854.x
  17. Kim, I.S., Y.W. Choi, Y. Kang, H.M. Sung, K.W. Sohn, and Y.S. Kim. 2008. Improvement of virus safety of an antihemophilic factor IX by virus filtration process. J. Microbiol. Biotechnol. 18, 1317-1325
  18. Kim, M., Y.H. Chung, and R.N. Johnston. 2007. Reovirus and tumor oncolysis. J. Microbiol. 45, 187-192
  19. Kim, S.H. and G.M. Lee. 2007. Differences in optimal pH and temperature for cell growth and antibody production between two Chinese hamster ovary clones derived from the same parental clone. J. Microbiol. Biotechnol. 17, 712-720
  20. Leary, T.P., J.C. Erker, M.L. Chalmers, J.D. Wetzel, S.M. Desai, I.K. Mushahwar, and T.S. Dermody. 2002. Detection of reovirus by reverse transcription-polymerase chain reaction using primers corresponding to conserved regions of the viral L1 genome segment. J. Virol. Methods 104, 161-165 https://doi.org/10.1016/S0166-0934(02)00058-7
  21. Liu, H.J., L.C. Kuo, Y.C. Hu, M.H. Liao, and Y.Y. Lien. 2002. Development of an ELISA for detection of antibodies to avian reovirus in chickens. J. Virol. Methods 102, 129-138 https://doi.org/10.1016/S0166-0934(02)00010-1
  22. London, B.A., J. Kern, and W.D. Gehle. 1983. Detection of murine virus antibody by ELISA. Lab. Animals 12, 40-47
  23. Merten, O.W. 2002. Virus contamination of cell cultures-a biotechnological view. Cytotechnol. 39, 91-116 https://doi.org/10.1023/A:1022969101804
  24. Nicklas, W., V. Kraft, and B. Meyer. 1993. Contamination of transplantable tumors, cell lines, and monoclonal antibodies with rodent viruses. Lab. Animal Sci. 43, 296-300
  25. Niebert, M.L and I.A. Schiff. 2001. Reoviruses and their replication, pp. 1679-1728. In B.N. Fields, D.M. Knipe, and P.M. Howley (eds.), Fields Virology. Lippincott-Raven, Philiadelphia, USA
  26. Parkman, P.D. 1996. Safety of biopharmaceuticals: a current perspective. Dev. Biol. Stand. 88, 5-7
  27. Schimidt, S., J. Mora, S. Dolan, and J. Kauling. 2005. An integrated concept for robust and efficient virus clearance and contaminant removal in biotech processes. BioProcess Int. 3, 26-31
  28. Uchiyama, A. and D.G. Besselsen. 2003. Detection of reovirus type 3 by use of fluorogenic nuclease reverse transcriptase polymerase chain reaction. Lab. Animals 37, 352-359 https://doi.org/10.1258/002367703103051903
  29. Walsh, G. 2002. Proteins: Biochemistry and Biotechnology, pp. 196-209. John Wiley & Sons Ltd, Baffins Lane, Chichester, West Sussex, England
  30. Wright, M.H., L.M. Cera, N.A. Sarich, and J.A. Lednicky. 2004. Reverse transcription-polymerase chain reaction detection and nucleic acid sequence confirmation of reovirus infection in laboratory mice with discordant serologic indirect immunofluorescence assay and enzyme-linked immunosorbent assay results. Comp. Med. 54, 410-417
  31. Zhan, D., M.R. Roy, C. Valera, J. Cardenas, J.C. Vennari, J.W. Che, and S. Liu. 2002. Detection of miute virus of mice using real time quantitative PCR in assessment of virus clearance during the purification of mammalian cell substrate derived biotherapeutics. Biologicals 30, 259-270 https://doi.org/10.1006/biol.2001.0284